Navigation Links
NOVAVAX Reports Third Quarter 2010 Financial Results
Date:11/5/2010

ent by other companies with greater resources and visibility; our ability to enter into future collaborations with industry partners and the terms, timing and success of any such collaboration; our ability to obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity or debt financing or otherwise; our inability to win any government contracts/grants, including from HHS BARDA, in a timely manner or if at all and other factors referenced herein.  Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov, including the factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, as updated by our Quarterly Report on Form 10-Q for the quarter ended June 30, 2010.  These forward-looking statements speak only as of the date of this earnings release and Novavax assumes no duty to update such statements.NOVAVAX, INC.CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS(in thousands, except per share information)(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2010200920102009Revenue$
75$
201$
292$
251Operating expenses:Research and development

7,8705,25623,22614,819General and administrative

2,8443,2078,5288,661Total operating expenses

10,7148,46331,75423,480Loss from operations

(10,539)(8,262)(31,462)(23,229)Interest income (expense), net

4840132(544)Other income

136-136-Impairment of short-term investments

---(1,338)Realized gains on short-term investments

-692-692Net loss$  (10,355)$   (7,530)$  (31,194)$   (24,419)Basic and diluted net loss per share

$
(0.10)$
(0.0
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novavax to Report Third Quarter 2010 Financial Results on November 5, 2010
2. NOVAVAX to Present at BIO Investor Forum
3. NOVAVAX to Present at Stifel Nicolaus Conference
4. NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures
5. NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
6. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
7. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
8. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
9. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
10. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
11. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Epic Sciences announced ... sequencing data, from metastatic castrate resistant prostate cancer ... American Society for Clinical Oncology. This application expands ... cell left behind™ platform to characterize circulating ... that late stage patients have heterogeneous clonal CTC ...
(Date:5/29/2015)... Calif. , May 29, 2015 ... data from two pivotal Phase 3, global, randomized, ... for the treatment of secondary hyperparathyroidism (SHPT) in ... Both studies met the primary endpoint, demonstrating that ... 416 groups achieved a greater than 30 percent ...
(Date:5/29/2015)... MALVERN, Pa. , May 29, 2015 /PRNewswire-USNewswire/ ... major focus of the Association for the Advancement ... 1995. With support from AAWC,s corporate ... Educational Portal on the AAWC website ... on a wound care pathway with links to ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7The Association for the Advancement of Wound Care Educates the Public 2
... Nov. 16, 2010 Questcor Pharmaceuticals, Inc. (Nasdaq: ... Maxim Group Growth Conference at 4:00 p.m. ET on Thursday, ... York. Don M. Bailey, President and Chief Executive Officer, will ... Attendance at this conference is by invitation only. A ...
... Eli Lilly and Company (NYSE: LLY ) ... compound patent for Alimta® (pemetrexed for injection) before the U.S. ... with a ruling from the court that judgment would be ... decision came in the case of Eli Lilly and ...
Cached Medicine Technology:Questcor to Present at the Maxim Group Growth Conference 2U.S. District Court Rules from Bench in Lilly's Favor, Confirms Validity of Alimta Patent 2
(Date:5/30/2015)... (PRWEB) May 30, 2015 The IRS ... 26th 2015, announcing that, “criminals used taxpayer-specific data acquired ... on approximately 100,000 tax accounts through IRS’ “Get Transcript” ... birth and street address.” , “You don’t even ... have to think it was only a matter of ...
(Date:5/29/2015)... 30, 2015 “In the current ... and federal regulations, we provide education that will ... who are suffering from pain, within the boundaries ... MD, professor of rehabilitation medicine and President/Medical Director ... Park, Kansas. , A new flight of PAINWeekEnd ...
(Date:5/29/2015)... FL (PRWEB) May 29, 2015 Ready to ... it’s important for all drivers to get their vehicles ready. ... to be prepared. Advanced Driving Systems (ADS) is ready to ... tips on preparing for summer road trips. , When planning ... the following to ensure that the trip goes smoothly and ...
(Date:5/29/2015)... The science of hair restoration has taken ... the efforts of internationally recognized hair transplant surgeon Dr. ... hair restoration and manual FUE techniques to offer ... , A Follicular Unit Extraction (FUE) is ... grafts from the donor areas of a patient. ...
(Date:5/29/2015)... The third annual Newport 10 Miler kicks ... new registration, starts outside the east wall of National ... event demonstrates the power of combining professional event management ... in this case, historic preservation. , The course ... Drive and passes by many Bellevue Avenue mansions. The ...
Breaking Medicine News(10 mins):Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3
... The International AIDS Society is grossly disappointed with the UN ... to facilitate all the earmarked prevention programs needed to battle ... of The International AIDS Society said 'The lack of clear ... of health workers we need in order to deliver prevention ...
... Indian biotech sector, the western region has claimed the ... by contributing 50 percent of the total revenues of ... the southern region. ,Giving an account of the ... Mazumdar-Shaw told the Bangalore Bio 2006 event here Wednesday ...
... Rajasthan man who has pledged not to marry till he passes ... a wife. He has failed in the examination yet again! // ... Behror town, over 140 km from here, has been taking the ... years of his life, he vowed to marry only after getting ...
... success of every person whether to be self-employed or not ... background and grown environment comparatively have lesser effect than genes ... of twins shows. It was also proved to be true ... College, London, and Case Western Reserve University in Cleveland, US. ...
... authorities of central Illinois they are going through a period of ... in the month of July and results in a couple of ... deaths crossed 66. But due to various precautionary measures and other ... reduced to 12 in 2005. It is mainly transmitted by a ...
... elderly people have died after an outbreak of tuberculosis at ... the fourth resident at the home is recovering after being ... NHS Lanarkshire said that four residents of the Eastercroft House ... three of those residents also had other long-standing medical problems ...
Cached Medicine News:Health News:Western Region Tops in Indian Biotech Growth 2
Maddox Rod, short handle (12cm)...
Graham Field 10' Reversed Snellen Eye Chart....
... PacScan 300AP is a portable, ... provides easy-to-use touch screen operation. ... frequency, low noise probes and ... capture immediately upon application of ...
Precision that fits in the palm of your hand and measures down to 125 microns, the Pocket Pachymeter is about 8" X 4" x 2" and really does fit in a lab coat pocket or briefcase....
Medicine Products: